IL-35 Over-expression is Associated with Genesis of Gastric Cancer |
Fan, Yong-Gang
(Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology)
Zhai, Jing-Ming (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) Wang, Wei (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) Feng, Bing (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) Yao, Guo-Liang (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) An, Yan-Hui (Departments of General Surgery, the First Affiliated Hospital of Henan University of Science and Technology) Zeng, Chao (Department of Pathology, Guangdong Medical College) |
1 | Collison LW, Workman CJ, Kuo TT, et al (2007). The inhibitory cytokine IL- 35 contributes to regulatory T- cell function. Nature, 450, 566-9. DOI |
2 | Collison LW, Chaturvedi V, Henderson AL, et al (2010). IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol, 11, 1093-101. DOI |
3 | Devergne O, Birkenbach M, Kieff E (1997). Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA, 94, 12041-6. DOI |
4 | Huang CH, Loo EX, Kuo IC, et al (2011). Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol, 187, 462-71. DOI |
5 | Kochetkova I, Golden S, Holderness K, et al (2010). IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. Immunol, 184, 7144-53. DOI |
6 | Larousserie F, Bardel E, Pflanz S, et al (2005). Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am J Pathol, 166, 1217-28. DOI |
7 | Li X, Mai J, Virtue A, et al (2012). IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines. PLoS One, 7, 33628. DOI |
8 | Long J, Zhang X, Wen M, et al (2013). IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun, 430, 364-9. DOI |
9 | Niedobitek G, Pazolt D, Teichmann M, et al (2002). Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol, 198, 310-6. DOI |
10 | Niedbala W, Wei XQ, Cai B, et al (2007). IL-35 is a novel cytokine with therapeutic effects against collagen- induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol, 37, 3021-9. DOI |
11 | Nishino R, Takano A, Oshita H, et al (2011). Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res, 17, 6272-86. DOI |
12 | Pflanz S, Timans JC, Cheung J, et al (2002). IL- 27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 (+) T cells. Immunity, 16, 779-90. DOI |
13 | Poleganov MA, Bachmann M, Pfeilschifter J, et al (2008). Genome-wide analysis displays marked induction of EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: critical role of two kappaB binding sites in the human EBI3 promotor. Mol Immunol, 45, 2869-80. DOI |
14 | Schrader JW (2002). Interleukin is as interleukin does. Trends Immunol, 23, 573-4. DOI |
15 | Seyerl M, Kirchberger S, Majdic O, et al (2010). Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol, 40, 321-9. DOI |
16 | Wang Z, Liu JQ, Liu Z, et al (2013). Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol, 190, 2415-23. DOI |
17 | Whitehead GS, Wilson RH, Nakano K, et al (2012). IL-35 production by inducible costimulator (ICOS)- positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol, 129, 207-15. DOI |
18 | Zeng JC1, Zhang Z, Li TY, et al (2013). Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int J Clin Exp Pathol, 6, 1806-16. |